Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Here's Why You Should Retain Integra LifeSciences (IART) Stock
11:22am, Wednesday, 31'st Mar 2021
Investors are optimistic about Integra LifeSciences (IART) stock, owing to its strong international business growth and focus on portfolio optimization.
Integra's (IART) Neurosurgery Rebounds Despite Supply Issues
09:51am, Wednesday, 31'st Mar 2021
Integra LifeSciences (IART) is confident of achieving long-term goals of 5% to 7% revenue growth organically,
Recovering Trauma Cases Should Highlight AxoGen's Improving Execution
12:19pm, Thursday, 11'th Mar 2021
Recovering Trauma Cases Should Highlight AxoGen's Improving Execution
Top Buys Today As Tech Leads And Dow Lags In Reverse Rotation
11:28am, Friday, 26'th Feb 2021
After the rise of 10-year yields terrified investors, the indices “reverse rotated” back into the Nasdaq and out of the Dow. Make the most of this market with today's top buys, from Q.ai's Artific
Integra (IART) Arms Grow Sequentially Despite Supply Issues
09:07am, Wednesday, 24'th Feb 2021
Integra LifeSciences (IART) is confident of achieving long-term goals of 5% to 7% revenue growth organically.
Integra (IART) Q4 Earnings Top Estimates, Revenues Fall Y/Y
10:35am, Friday, 19'th Feb 2021
Integra (IART) fourth-quarter 2020 revenues fell 1.6% year over year to $388.6 million but rose 5% sequentially.
Integra LifeSciences Announces Participation in Upcoming Investor Conferences
08:00am, Friday, 19'th Feb 2021
PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in th
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q4 2020 Results - Earnings Call Transcript
04:45pm, Thursday, 18'th Feb 2021
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q4 2020 Results - Earnings Call Transcript
Integra LifeSciences (IART) Surpasses Q4 Earnings and Revenue Estimates
08:20am, Thursday, 18'th Feb 2021
Integra (IART) delivered earnings and revenue surprises of 13.51% and 0.29%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Integra Lifesciences Q4 Earnings
07:47am, Thursday, 18'th Feb 2021
Shares of Integra Lifesciences (NASDAQ:IART) moved higher by 0.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 23.53% year over year to $
Integra Lifesciences' Q4 Earnings Come In Above Expectations, Issues Soft Q1 Guidance
07:39am, Thursday, 18'th Feb 2021
Integra Lifesciences Holdings Corp (NASDAQ: IART) reported Q4 adjusted EPS $0.84 better than the consensus estimate of $0.73 and revenues of $388.6 million in line with expectations. Revenues decl
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
06:00am, Thursday, 18'th Feb 2021
PRINCETON, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December 31, 20
Integra (IART) Acquires Acell, Focuses on Regenerative Space
10:32am, Thursday, 21'st Jan 2021
The acquisition is expected to remain accretive to Integra's (IART) revenue growth and adjusted gross margins.
Integra LifeSciences Completes the Acquisition of ACell, Inc.
08:40am, Wednesday, 20'th Jan 2021
PRINCETON, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it completed the previously-dis
Integra (IART) Preliminary Q4 Reported Sales Show Recovery
09:47am, Friday, 15'th Jan 2021
Integra's (IART) sales improvement in the fourth quarter is likely to have been boosted by on-going business recovery.
